← Back to Search

Joint Replacement

Triathlon PKR for Knee Replacement Surgery (PKR Trial)

N/A
Waitlist Available
Led By Paul Jacob, MD
Research Sponsored by Stryker Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-years
Awards & highlights

PKR Trial Summary

This trial is comparing the long-term effects of two different types of knee replacements.

PKR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Investigation of Clinical Performance and Patient Outcome With the Functional Knee Society Score (KSS).
Secondary outcome measures
10-years Kaplan Meier Survival Analysis

PKR Trial Design

1Treatment groups
Experimental Treatment
Group I: Triathlon PKRExperimental Treatment1 Intervention
All subjects enrolled will receive the Triathlon PKR device.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Triathlon PKR
2013
N/A
~70

Find a Location

Who is running the clinical trial?

Stryker OrthopaedicsLead Sponsor
78 Previous Clinical Trials
20,322 Total Patients Enrolled
Paul Jacob, MDPrincipal InvestigatorOklahoma Sports Science and Orthopaedics
Soren Toksvig-Larsen, MDPrincipal InvestigatorHassleholm Sygehus Ortopaedkirurgisk afd.

Media Library

Triathlon® Partial Knee Replacement (PKR) (Joint Replacement) Clinical Trial Eligibility Overview. Trial Name: NCT00966979 — N/A
Knee Replacement Surgery Research Study Groups: Triathlon PKR
Knee Replacement Surgery Clinical Trial 2023: Triathlon® Partial Knee Replacement (PKR) Highlights & Side Effects. Trial Name: NCT00966979 — N/A
Triathlon® Partial Knee Replacement (PKR) (Joint Replacement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00966979 — N/A
~7 spots leftby Jun 2025